Song B
Int J Mol Sci. 2025; 26(5).
PMID: 40076976
PMC: 11900391.
DOI: 10.3390/ijms26052357.
Zeng M, Zhang Q, Ke F
Int J Mol Sci. 2025; 26(4).
PMID: 40004028
PMC: 11855584.
DOI: 10.3390/ijms26041554.
Yee B, Ali N, Mohd-Naim N, Ahmed M
Chem Bio Eng. 2025; 1(4):330-339.
PMID: 39974464
PMC: 11835143.
DOI: 10.1021/cbe.3c00112.
Ahmadikhah A, Zarabizadeh H, Nayeri S, Abbasi M
Front Plant Sci. 2025; 15:1370675.
PMID: 39963359
PMC: 11830681.
DOI: 10.3389/fpls.2024.1370675.
Owaid H, Al-Ouqaili M
Heliyon. 2025; 11(1):e41670.
PMID: 39866497
PMC: 11761341.
DOI: 10.1016/j.heliyon.2025.e41670.
Are You My Host? An Overview of Methods Used to Link Bacteriophages with Hosts.
Hyman P
Viruses. 2025; 17(1).
PMID: 39861854
PMC: 11769497.
DOI: 10.3390/v17010065.
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.
Ma J, Lu Z
Microorganisms. 2025; 13(1).
PMID: 39858940
PMC: 11767912.
DOI: 10.3390/microorganisms13010172.
Bacteriophages: A Challenge for Antimicrobial Therapy.
Segundo-Arizmendi N, Arellano-Maciel D, Rivera-Ramirez A, Pina-Gonzalez A, Lopez-Leal G, Hernandez-Baltazar E
Microorganisms. 2025; 13(1).
PMID: 39858868
PMC: 11767365.
DOI: 10.3390/microorganisms13010100.
Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections.
Naveed M, Waseem M, Mahkdoom I, Ali N, Asif F, Hassan J
Front Antibiot. 2025; 2():1309107.
PMID: 39816650
PMC: 11732137.
DOI: 10.3389/frabi.2023.1309107.
CRISPR/Cas9 System as a Promising Therapy in Thalassemia and Sickle Cell Disease: A Systematic Review of Clinical Trials.
Ahmed R, Alghamdi W, Alharbi F, Alatawi H, Alenezi K, Alanazi T
Mol Biotechnol. 2025; .
PMID: 39794549
DOI: 10.1007/s12033-025-01368-x.
Recent developments and future directions in point-of-care next-generation CRISPR-based rapid diagnosis.
Hassan Y, Mohamed A, Hassan Y, El-Sayed W
Clin Exp Med. 2025; 25(1):33.
PMID: 39789283
PMC: 11717804.
DOI: 10.1007/s10238-024-01540-8.
Determination of Technological Properties and CRISPR Profiles of Isolates Obtained from Local Yogurt Samples.
Coban H, Olgun D, Temur I, Durak M
Microorganisms. 2025; 12(12.
PMID: 39770631
PMC: 11679738.
DOI: 10.3390/microorganisms12122428.
Efficient genome editing in medaka () using a codon-optimized SaCas9 system.
Jiang Y, Pan Q, Wang Z, Lu K, Xia B, Chen T
J Zhejiang Univ Sci B. 2025; 25(12):1083-1096.
PMID: 39743295
PMC: 11693391.
DOI: 10.1631/jzus.B2300899.
Recent progress in prompt molecular detection of liquid biopsy using Cas enzymes: innovative approaches for cancer diagnosis and analysis.
Yazdi Z, Roshannezhad S, Sharif S, Abbaszadegan M
J Transl Med. 2024; 22(1):1173.
PMID: 39741289
PMC: 11686959.
DOI: 10.1186/s12967-024-05908-y.
CRISPR-Cas13a Targeting the FGFR3-TACC3 Fusion Gene Inhibits Proliferation of Bladder Cancer Cells in vitro and in vivo.
Wang Y, Zhu J, Liu S, Sun Z, Wen G, Huang D
Onco Targets Ther. 2024; 17:1197-1207.
PMID: 39717713
PMC: 11664097.
DOI: 10.2147/OTT.S492659.
Delving deep into the draft genome of Mangrovibacter sp. SLW1, isolated from Sundarbans mangrove.
Roy A, Ghosh A, Bhadury P
Access Microbiol. 2024; 6(8).
PMID: 39697668
PMC: 11652732.
DOI: 10.1099/acmi.0.000847.v3.
Research Progress on the Mechanism and Application of the Type I CRISPR-Cas System.
Yang P, Zhang S, Hu D, Li X, Guo Y, Guo H
Int J Mol Sci. 2024; 25(23).
PMID: 39684256
PMC: 11640852.
DOI: 10.3390/ijms252312544.
Advances and applications of CRISPR/Cas-mediated interference in .
Lim X, Zhang C, Chen X
Eng Microbiol. 2024; 4(1):100123.
PMID: 39628789
PMC: 11611006.
DOI: 10.1016/j.engmic.2023.100123.
CRISPR-Cas Systems in the Fight Against Antimicrobial Resistance: Current Status, Potentials, and Future Directions.
Ahmed M, Kayode H, Okesanya O, Ukoaka B, Eshun G, Mourid M
Infect Drug Resist. 2024; 17:5229-5245.
PMID: 39619730
PMC: 11608035.
DOI: 10.2147/IDR.S494327.
Engineering stimuli-responsive CRISPR-Cas systems for versatile biosensing.
Cao L, Chen W, Kang W, Lei C, Nie Z
Anal Bioanal Chem. 2024; .
PMID: 39601843
DOI: 10.1007/s00216-024-05678-y.